Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study
M Buchynskyi, V Oksenych, I Kamyshna… - Frontiers in …, 2024 - frontiersin.org
This study investigated the influence of single nucleotide polymorphisms (SNPs) in genes
associated with the interferon pathway (IFNAR2 rs2236757), antiviral response (OAS1 …
associated with the interferon pathway (IFNAR2 rs2236757), antiviral response (OAS1 …
[HTML][HTML] Metformin in Antiviral Therapy: Evidence and Perspectives
Metformin, a widely used antidiabetic medication, has emerged as a promising broad-
spectrum antiviral agent due to its ability to modulate cellular pathways essential for viral …
spectrum antiviral agent due to its ability to modulate cellular pathways essential for viral …
Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes
M Buchynskyi, V Oksenych, I Kamyshna, I Vorobets… - Viruses, 2024 - mdpi.com
Metabolic-associated fatty liver disease (MAFLD) is a risk factor for severe COVID-19. This
study explores the potential influence of gut hormone receptor and immune response gene …
study explores the potential influence of gut hormone receptor and immune response gene …
Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in MAFLD and COVID-19 Outcomes
M Buchynskyi, V Oksenych, I Kamyshna, I Vorobets… - 2024 - preprints.org
Metabolic-associated fatty liver disease (MAFLD) is a risk factor for severe COVID-19. This
study explores the potential influence of gut hormone receptor and immune response gene …
study explores the potential influence of gut hormone receptor and immune response gene …
[PDF][PDF] Pharmacogenetics Determinants of Paxlovid Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in Modulating COVID-19 Patient Outcomes
This study aimed to investigate the impact of specific single nucleotide polymorphisms
(SNPs) on clinical and laboratory outcomes in COVID-19 patients receiving Paxlovid …
(SNPs) on clinical and laboratory outcomes in COVID-19 patients receiving Paxlovid …